INTERNATIONAL PATENT: ANTABIO SAS FILES APPLICATION FOR "DOSING REGIMEN COMPRISING (2R,5R)-2-FLUORO-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTAN-6-YL HYDROGEN SULPHATE AND A BETA-LACTAM ANTIBIOTIC"

GENEVA, Oct. 19 -- ANTABIO SAS (Biostep436 Rue Pierre et Marie Curie31 670 Labege) filed a patent application (PCT/EP2025/060159) for "DOSING REGIMEN COMPRISING (2R,5R)-2-FLUORO-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTAN-6-YL HYDROGEN SULPHATE AND A BETA-LACTAM ANTIBIOTIC" on Apr 11, 2025. With publication no. WO/2025/215253, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZWINGELSTEIN, Christian (c/o Antabio SASBiostep436 Rue Pierre et Marie Curie31 670 Labege), ZALACAIN, Magdalena (c/o Antabio SASBiostep436 Rue Pierre et Marie ...